Pages that link to "Q54582564"
Jump to navigation
Jump to search
The following pages link to HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination. (Q54582564):
Displaying 27 items.
- Modulation of T-cell activation by malignant melanoma initiating cells (Q24595394) (← links)
- Stem cells and targeted approaches to melanoma cure (Q26825014) (← links)
- A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens (Q27023313) (← links)
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genes (Q36419244) (← links)
- IFN inducibility of major histocompatibility antigens in tumors (Q37341021) (← links)
- Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer (Q37598077) (← links)
- Testing the theory of immune selection in cancers that break the rules of transplantation (Q37662210) (← links)
- Strategies to counteract MHC-I defects in tumors (Q37836060) (← links)
- The role of stem and circulating cells in cancer metastasis (Q37863625) (← links)
- Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma (Q37902639) (← links)
- Targeting HLA class I expression to increase tumor immunogenicity (Q37981721) (← links)
- Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype. (Q38282541) (← links)
- Vaccines for established cancer: overcoming the challenges posed by immune evasion (Q38769021) (← links)
- Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation (Q39396738) (← links)
- Immunotherapy eradicates metastases with reversible defects in MHC class I expression (Q39546174) (← links)
- Ultra scale-down studies of the effect of shear on cell quality; Processing of a human cell line for cancer vaccine therapy (Q39820384) (← links)
- NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8( ) T lymphocytes (Q40595500) (← links)
- Antitumor immunity and cancer stem cells (Q41520738) (← links)
- Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. (Q41862292) (← links)
- High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine. (Q45868564) (← links)
- Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells. (Q54408630) (← links)
- Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells. (Q55364385) (← links)
- Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy (Q81436256) (← links)
- Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors (Q82496617) (← links)
- Melanoma stem cells: not rare, but well done (Q83737928) (← links)
- Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics (Q91790659) (← links)
- MHC/HLA Class I Loss in Cancer Cells (Q92364680) (← links)